Skip to main content

Table 2 Comparison of patient characteristics according to the presence of HIV-related neuroimaging abnormalities (NA).

From: Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study

 

HIV patients without NA (n = 15)

HIV patients with NA (n = 5)

p-value

Age*

12.35 ± 4.5

10 ± 6.0

0.371†

HIV Treatment

   

   HAART

9 (60.0%)

2 (40.0%)

0.298‡

   HAART + AZT

6 (40.0%)

3 (60.0%)

-

Age of HAART Initiation*

6.59 ± 3.9

4.3 ± 5

0.306†

Months on HAART *

5.75 ± 2.3

5.7 ± 2.5

0.964†

Stage

  

0.026§

   A1

2 (13.3%)

0 (0.0%)

 

   B1 or B2 or B3

13 (86.7%)

4 (80.0%)

 

   C1 or C3

0 (0.0%)

1 (20.0%)

 

Viral Load

  

0.528§

   < 40

5 (33.3%)

1 (20.0%)

 

   40-1000

8 (53.3%)

4 (80.0%)

 

   1000-10 000

2 (13.3%)

0 (0.0%)

 

CD4 count

  

0.140§

   < 200 cells

1 (6.7%)

2 (40.0%)

 

   200-500 cells

1 (6.7%)

0 (0.0%)

 

   > 500 cells

13 (86.7%)

3 (60.0%)

 
  1. *Data expressed in mean years ± SD
  2. † Student's t-test p-value
  3. ‡ Fisher's exact test p-value
  4. § Wilcoxon rank-sum test p-value
Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us